He was an assistant professor at Emory University School of medicine, independent PI, with 12 years of basic and clinical drug R & D experience;
He has published more than ten SCI academic papers, presided over and participated in the R & D and clinical trials of a number of new drugs (phase I-III), including myocardial ischemia-reperfusion injury, heart failure, anti-tumor, myocarditis, atherosclerosis, influenza vaccine development, etc;
Bachelor of genetics, University of Sheffield, UK, doctor of cell and molecular biology, Imperial College of technology, UK, and postdoctoral fellow of Affiliated Hospital of Lund University, Sweden and National Institutes of Health (NIH)
He has published more than ten SCI academic papers, presided over and participated in the R & D and clinical trials of a number of new drugs (phase I-III), including myocardial ischemia-reperfusion injury, heart failure, anti-tumor, myocarditis, atherosclerosis, influenza vaccine development, etc;
Bachelor of genetics, University of Sheffield, UK, doctor of cell and molecular biology, Imperial College of technology, UK, and postdoctoral fellow of Affiliated Hospital of Lund University, Sweden and National Institutes of Health (NIH)
请将简历发送至：